Aramark has a consensus price target of $37.62 based on the ratings of 17 analysts. The high is $49 issued by Bernstein on July 17, 2023. The low is $29 issued by Jefferies on October 9, 2023. The 3 most-recent analyst ratings were released by UBS, Oppenheimer, and Baird on June 21, 2024, June 12, 2024, and May 8, 2024, respectively. With an average price target of $38.67 between UBS, Oppenheimer, and Baird, there's an implied 17.81% upside for Aramark from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/21/2024 | Buy Now | 21.88% | UBS | Joshua Chan | $35 → $40 | Maintains | Buy | Get Alert |
06/12/2024 | Buy Now | 18.83% | Oppenheimer | Ian Zaffino | $36 → $39 | Maintains | Outperform | Get Alert |
05/08/2024 | Buy Now | 12.74% | Baird | Andrew Wittmann | $35 → $37 | Maintains | Neutral | Get Alert |
03/20/2024 | Buy Now | 12.74% | Truist Securities | Jasper Bibb | $35 → $37 | Maintains | Buy | Get Alert |
02/07/2024 | Buy Now | 6.64% | UBS | Joshua Chan | $32 → $35 | Maintains | Buy | Get Alert |
02/07/2024 | Buy Now | -8.59% | Morgan Stanley | Toni Kaplan | $28 → $30 | Maintains | Equal-Weight | Get Alert |
02/07/2024 | Buy Now | 6.64% | Truist Securities | Jasper Bibb | $33 → $35 | Maintains | Buy | Get Alert |
02/07/2024 | Buy Now | 0.55% | RBC Capital | Ashish Sabadra | → $33 | Reiterates | Sector Perform → Sector Perform | Get Alert |
01/17/2024 | Buy Now | 0.55% | Goldman Sachs | Lizzie Dove | → $33 | Initiates | → Buy | Get Alert |
01/08/2024 | Buy Now | 0.55% | Truist Securities | Jasper Bibb | → $33 | Initiates | → Buy | Get Alert |
01/04/2024 | Buy Now | -2.5% | UBS | Joshua Chan | $31 → $32 | Maintains | Buy | Get Alert |
11/15/2023 | Buy Now | -5.55% | UBS | Joshua Chan | $29 → $31 | Maintains | Buy | Get Alert |
11/15/2023 | Buy Now | -20.78% | Morgan Stanley | Toni Kaplan | $27 → $26 | Maintains | Equal-Weight | Get Alert |
11/07/2023 | Buy Now | 0.55% | Stifel | Shlomo Rosenbaum | $45 → $33 | Maintains | Buy | Get Alert |
10/16/2023 | Buy Now | 6.64% | JP Morgan | Andrew Steinerman | $47 → $35 | Maintains | Overweight | Get Alert |
10/10/2023 | Buy Now | 11.21% | Citigroup | James Ainley | $33.93 → $36.5 | Maintains | Buy | Get Alert |
10/09/2023 | Buy Now | -17.73% | Morgan Stanley | Toni Kaplan | $44 → $27 | Maintains | Equal-Weight | Get Alert |
10/09/2023 | Buy Now | -11.64% | Jefferies | Stephanie Moore | $44 → $29 | Upgrade | Hold → Buy | Get Alert |
10/05/2023 | Buy Now | -11.64% | UBS | Joshua Chan | $43 → $29 | Maintains | Buy | Get Alert |
10/05/2023 | Buy Now | -14.69% | Oppenheimer | Ian Zaffino | $50 → $28 | Maintains | Outperform | Get Alert |
09/25/2023 | Buy Now | 31.02% | RBC Capital | Ashish Sabadra | $48 → $43 | Maintains | Sector Perform | Get Alert |
09/14/2023 | Buy Now | 37.11% | Stifel | Shlomo Rosenbaum | → $45 | Reiterates | Buy → Buy | Get Alert |
09/08/2023 | Buy Now | 43.21% | B of A Securities | Gary Bisbee | $48 → $47 | Maintains | Buy | Get Alert |
09/01/2023 | Buy Now | 43.21% | Citigroup | James Ainley | $45 → $47 | Upgrade | Neutral → Buy | Get Alert |
08/22/2023 | Buy Now | 31.02% | UBS | Joshua Chan | → $43 | Upgrade | Neutral → Buy | Get Alert |
08/10/2023 | Buy Now | 15.78% | Barclays | Manav Patnaik | $36 → $38 | Maintains | Underweight | Get Alert |
08/09/2023 | Buy Now | 43.21% | JP Morgan | Andrew Steinerman | $42 → $47 | Maintains | Overweight | Get Alert |
08/09/2023 | Buy Now | 34.06% | Morgan Stanley | Toni Kaplan | $41 → $44 | Maintains | Equal-Weight | Get Alert |
07/17/2023 | Buy Now | 49.3% | Bernstein | Harry Martin | → $49 | Assumes | Market Perform → Outperform | Get Alert |
06/01/2023 | Buy Now | 27.97% | UBS | Joshua Chan | → $42 | Initiates | → Neutral | Get Alert |
05/10/2023 | Buy Now | 46.25% | RBC Capital | Ashish Sabadra | → $48 | Reiterates | → Sector Perform | Get Alert |
05/10/2023 | Buy Now | 24.92% | Morgan Stanley | Toni Kaplan | $40 → $41 | Maintains | Equal-Weight | Get Alert |
04/19/2023 | Buy Now | 15.78% | Bernstein | Harry Martin | → $38 | Initiates | → Market Perform | Get Alert |
04/04/2023 | Buy Now | 27.97% | Stifel | Shlomo Rosenbaum | $45 → $42 | Maintains | Buy | Get Alert |
03/22/2023 | Buy Now | 18.83% | Baird | Andrew Wittmann | $43 → $39 | Maintains | Neutral | Get Alert |
03/21/2023 | Buy Now | 21.88% | Morgan Stanley | Toni Kaplan | $43 → $40 | Maintains | Equal-Weight | Get Alert |
03/20/2023 | Buy Now | 24.92% | JP Morgan | Andrew Steinerman | $44 → $41 | Maintains | Overweight | Get Alert |
02/08/2023 | Buy Now | 31.02% | Morgan Stanley | Toni Kaplan | $44 → $43 | Maintains | Equal-Weight | Get Alert |
02/08/2023 | Buy Now | 46.25% | RBC Capital | Ashish Sabadra | → $48 | Reiterates | → Sector Perform | Get Alert |
02/08/2023 | Buy Now | 34.06% | JP Morgan | Andrew Steinerman | $45 → $44 | Maintains | Overweight | Get Alert |
01/27/2023 | Buy Now | 37.11% | Citigroup | James Ainley | $39 → $45 | Maintains | Neutral | Get Alert |
01/04/2023 | Buy Now | 34.06% | Morgan Stanley | Toni Kaplan | $41 → $44 | Maintains | Equal-Weight | Get Alert |
12/02/2022 | Buy Now | 9.69% | Barclays | Manav Patnaik | $34 → $36 | Maintains | Underweight | Get Alert |
11/16/2022 | Buy Now | 31.02% | Deutsche Bank | Faiza Alwy | $40 → $43 | Maintains | Hold | Get Alert |
11/16/2022 | Buy Now | 24.92% | Morgan Stanley | Toni Kaplan | $38 → $41 | Maintains | Equal-Weight | Get Alert |
11/16/2022 | Buy Now | 37.11% | RBC Capital | Ashish Sabadra | $38 → $45 | Maintains | Sector Perform | Get Alert |
10/25/2022 | Buy Now | 9.69% | Jefferies | Stephanie Moore | → $36 | Assumes | → Hold | Get Alert |
10/13/2022 | Buy Now | 15.78% | RBC Capital | Ashish Sabadra | $41 → $38 | Maintains | Sector Perform | Get Alert |
09/27/2022 | Buy Now | 15.78% | Morgan Stanley | Toni Kaplan | $37 → $38 | Maintains | Equal-Weight | Get Alert |
08/10/2022 | Buy Now | 21.88% | Deutsche Bank | Faiza Alwy | $38 → $40 | Maintains | Hold | Get Alert |
08/10/2022 | Buy Now | 12.74% | Morgan Stanley | Toni Kaplan | $35 → $37 | Maintains | Equal-Weight | Get Alert |
07/20/2022 | Buy Now | 6.64% | Morgan Stanley | Toni Kaplan | $37 → $35 | Maintains | Equal-Weight | Get Alert |
05/11/2022 | Buy Now | 12.74% | Morgan Stanley | Toni Kaplan | $38 → $37 | Maintains | Equal-Weight | Get Alert |
03/30/2022 | Buy Now | 15.78% | Deutsche Bank | Faiza Alwy | → $38 | Initiates | → Hold | Get Alert |
01/05/2022 | Buy Now | 21.88% | Morgan Stanley | Toni Kaplan | $39 → $40 | Maintains | Equal-Weight | Get Alert |
12/10/2021 | Buy Now | 18.83% | Morgan Stanley | Toni Kaplan | — | Maintains | Equal-Weight | Get Alert |
11/19/2021 | Buy Now | 21.88% | Citigroup | — | — | Maintains | Neutral | Get Alert |
11/02/2021 | Buy Now | 24.92% | RBC Capital | Ashish Sabadra | — | Maintains | Sector Perform | Get Alert |
10/21/2021 | Buy Now | 21.88% | Berenberg | Stuart Gordon | — | Upgrade | Hold → Buy | Get Alert |
09/17/2021 | Buy Now | -2.5% | Barclays | Manav Patnaik | — | Downgrade | Equal-Weight → Underweight | Get Alert |
The latest price target for Aramark (NYSE:ARMK) was reported by UBS on June 21, 2024. The analyst firm set a price target for $40.00 expecting ARMK to rise to within 12 months (a possible 21.88% upside). 28 analyst firms have reported ratings in the last year.
The latest analyst rating for Aramark (NYSE:ARMK) was provided by UBS, and Aramark maintained their buy rating.
The last upgrade for Aramark happened on October 9, 2023 when Jefferies raised their price target to $29. Jefferies previously had a hold for Aramark.
The last downgrade for Aramark happened on September 17, 2021 when Barclays changed their price target from $35 to $32 for Aramark.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aramark, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aramark was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
While ratings are subjective and will change, the latest Aramark (ARMK) rating was a maintained with a price target of $35.00 to $40.00. The current price Aramark (ARMK) is trading at is $32.82, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.